At the invitation of Bard Diagnostics of NYC, internationally-recognized imaging specialist Dr. Robert Bard welcomed Dr. Jason Cooney, DC, to New York City to showcase Scrambler Therapy’s success treating chemotherapy-induced peripheral neuropathy (CIPN).
When cancer specialists encounter a treatment-resistant complication affecting many of their patients, they look for answers. That was the context behind a recent meeting in New York City, where Dr. Jason Cooney, DC, of Scrambler Therapy NJ USA was invited to demonstrate Scrambler Therapy at the respected Bard Diagnostics of NYC.
The invitation came from Robert Bard, an internationally recognized expert in cancer diagnostics and advanced medical imaging. At his New York City center, Dr. Bard has spent decades advancing technologies that help physicians visualize subtle biological changes occurring within tissue during disease and treatment.
For Dr. Bard and his team, the focus of the meeting was a growing problem in oncology: chemotherapy-induced peripheral neuropathy (CIPN).
A New Approach to a Difficult Cancer Treatment Complication
CIPN affects many cancer survivors after chemotherapy. Patients often experience persistent burning, tingling, numbness, or electric-like pain in their hands and feet—symptoms that can last for years and frequently resist conventional medications.
Scrambler Therapy is an FDA-cleared neuromodulation treatment designed to retrain how the brain interprets chronic pain signals. Instead of masking symptoms with medication, the therapy delivers synthetic “non-pain” information through surface electrodes placed on the skin, helping the nervous system reinterpret incoming signals.
Dr. Cooney has spent years focusing on these treatment-resistant neuropathic pain conditions, including CIPN, treating patients ranging from children to seniors.
Because CIPN remains a major quality-of-life issue for cancer survivors, Dr. Bard specifically invited Dr. Cooney to demonstrate how Scrambler Therapy works in practice.
Demonstrating Scrambler Therapy with Advanced Imaging
During the visit, Dr. Cooney set up the Scrambler Therapy system and applied treatment leads while Dr. Bard used his advanced diagnostic ultrasound equipment to observe physiologic changes in real time.
The purpose of the demonstration was to explore whether imaging technology could help measure changes in blood flow, inflammation, and muscle tone during a Scrambler treatment session.
Traditionally, the effectiveness of neuropathic pain treatments has been evaluated largely through patient-reported pain scores. Dr. Bard’s imaging technology may help physicians observe measurable biological responses occurring during treatment—potentially providing additional insight into how neuromodulation therapies affect the body.
For cancer centers managing complex neuropathic complications, this type of collaboration reflects a growing interest in combining advanced imaging with innovative pain therapies.
Growing Recognition in the Treatment of Neuropathic Pain
The meeting also highlights Dr. Cooney’s growing reputation among clinicians managing treatment-resistant chronic pain in patients of all ages.
Patients with chemotherapy-induced peripheral neuropathy often travel significant distances seeking relief after medications, injections, and other conventional treatments fail. Scrambler Therapy has increasingly attracted attention among physicians searching for drug-free approaches to chronic nerve pain.
By connecting with specialists such as Dr. Bard, collaborations like this one may help further expand clinical understanding of how neuromodulation therapies work—and how they may help cancer survivors regain comfort and function after treatment.
Is FDA-cleared, non-invasive scrambler therapy right for your neuropathy?
Call Scrambler Therapy NJ USA in Clifton, NJ, at 201-933-4440 or complete our online Consultation Request to speak directly with Dr. Cooney about the possibility of scrambler therapy for your neuropathic pain condition. Learn more about Dr. Robert Bard and the Bard Diagnostics of NYC.
